Agios Pharmaceuticals | Driftskostnader

Operating Expenses Endring Dato
AbbVie USD 9.35B 1.76B 2024-03
Agios Pharmaceuticals USD 100.26M 13.12M 2024-03
Alnylam Pharmaceuticals USD 537.77M 18.35M 2024-03
Amgen USD 6.46B 469M 2024-03
Arrowhead Research USD 126.19M 13.9M 2024-03
Astellas Pharma JPY 402.97B 16.05B 2023-12
AstraZeneca USD 9.56B 1.23B 2024-03
Bayer EUR 10.67B 1000M 2024-03
Biogen USD 1.72B 306.9M 2024-03
BioMarin Pharmaceutical USD 570.37M 61.62M 2024-03
Bristol-Myers Squibb USD 10.35B 728M 2024-03
Daiichi Sankyo JPY 347.44B 22.96B 2023-12
Eli Lilly USD 6.03B 933.2M 2024-03
Exelixis USD 362.93M 126.57M 2024-03
Gilead Sciences USD 6.88B 1.37B 2024-03
GlaxoSmithKline GBP 5.87B 1.61B 2024-03
Incyte USD 789.54M 36.54M 2024-03
Ionis Pharmaceuticals USD 269.01M 34.82M 2024-03
Merck USD 10.02B 6.55B 2024-03
Moderna USD 1.43B 1.37B 2024-03
Novartis USD 8.75B 447M 2024-03
Novartis USD 8.75B 447M 2024-03
Pfizer USD 10.68B 10.12B 2024-03
Regeneron Pharmaceuticals USD 2.39B 74.9M 2024-03
Roche Holding CHF 20.02B 5.04B 2023-06
Sarepta Therapeutics USD 378.56M 1.6M 2024-03
Vertex Pharmaceuticals USD 1.47B 29M 2024-03



Agios Pharmaceuticals Driftskostnader - Gjeldende verdier, historiske data, prognoser, statistikk, diagrammer og økonomiske kalender - Jun 2024.